UBS upgrades IBM stock rating on balanced risk-reward outlook
#UBS #IBM #Stock Rating Upgrade #Risk-Reward Profile #AI Technology #Market Performance #Valuation Metrics #Price Target
📌 Key Takeaways
- UBS upgraded IBM from Sell to Neutral with $236 price target
- IBM stock has declined 22% in 2026 and underperformed S&P 500 by 27%
- UBS expects 3-4% organic revenue growth for IBM in coming years
- IBM trades at attractive valuation with low PEG ratio of 0.27
📖 Full Retelling
UBS upgraded IBM (NYSE:IBM) stock to Neutral from Sell on Wednesday, February 25, 2026, setting a price target of $236.00 as the investment bank determined the risk-reward profile for IBM shares has become more balanced. The upgrade comes after IBM shares have declined 22% in 2026 and significantly underperformed the S&P 500 by almost 27% over the past 12 months following a series of uneven quarterly results in 2025. IBM now trades at approximately 18.5 times UBS's 2026 earnings per share estimate of $12.43 and 17.5 times its 2027 estimate of $13.13, with the stock currently sporting a P/E ratio of 20.6 and a notably low PEG ratio of 0.27, suggesting attractive valuation relative to growth prospects. UBS expects IBM to deliver 3% to 4% organic revenue growth over the next several years, while acknowledging that the stock's 7% free cash flow yield largely reflects competitive risk to IBM's Z vertically integrated platform from artificial intelligence across the software landscape. Market concerns center on whether AI-powered translation of legacy COBOL will hurt IBM's infrastructure business, though UBS does not expect mainframe disintermediation over the next several years due to strong customer stickiness, data sovereignty requirements, and a complex vertically integrated stack that provides quantum-safe encryption.
🏷️ Themes
Stock Rating Changes, AI Technology Impact, Company Valuation, Market Performance
📚 Related People & Topics
UBS
Multinational investment bank headquartered in Switzerland
UBS Group AG (stylized simply as UBS) is a Swiss multinational investment bank and financial services firm founded and based in Switzerland, with headquarters in both Zurich and Basel. It holds a strong foothold in all major financial centres as the largest Swiss banking institution and the world's ...
IBM
American multinational technology company
International Business Machines Corporation, doing business as IBM (nicknamed Big Blue), is an American multinational technology company headquartered in Armonk, New York, and present in over 175 countries. It is a publicly traded company and one of the 30 companies in the Dow Jones Industrial Avera...
Entity Intersection Graph
Connections for UBS:
🌐
London Stock Exchange
2 shared
🏢
SSP Group
2 shared
🏢
FinecoBank
1 shared
🌐
Commercial policy
1 shared
🌐
Capital (economics)
1 shared
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry AMD stock surges 14% on Meta AI partnership deal Bitcoin slips, wipes out 50% from October record high at session low Wall Street ends higher on tech rebound ahead of State of the Union address Software stocks rebound as Anthropic partnerships ease AI disruption fears (South Africa Philippines Nigeria) UBS upgrades IBM stock rating on balanced risk-reward outlook By Investing.com Analyst Ratings Published 02/25/2026, 01:27 AM UBS upgrades IBM stock rating on balanced risk-reward outlook 0 US500 0.77% IBM 2.67% Investing.com - UBS upgraded IBM (NYSE:IBM) to Neutral from Sell on Wednesday and set a price target of $236.00. The firm said the risk-reward profile for IBM shares is now more balanced. IBM shares have declined 22% in 2026 and underperformed the S&P 500 by almost 27% over the past 12 months following a series of uneven quarters in 2025. IBM now trades at approximately 18.5 times UBS’s 2026 earnings per share estimate of $12.43 and 17.5 times its 2027 estimate of $13.13. The stock currently has a P/E ratio of 20.6 with a notably low PEG ratio of 0.27, suggesting attractive valuation relative to growth prospects. InvestingPro data indicates IBM is undervalued based on its Fair Value analysis, placing it among stocks on the Most Undervalued list . UBS expects IBM to deliver 3% to 4% organic revenue growth over the next several years. The stock trades at a 7% free cash flow yield, which UBS said largely reflects competitive risk to IBM’s Z vertically integrated platform from artificial intelligence across the software landscape. Market concerns center on whether AI-powered translation of legacy COBOL will hurt IBM’s infrastructure business. UBS said it does not expect mainframe disintermediation over the next several years due to strong customer stickiness, data sovereignty requirements and a complex vertically integrated stack that provides quantum-safe encryption. The firm continues to expect flat infra...
Read full article at source